Veerhealth Care Reports 474.18% YoY Growth in PAT and 73.13% in Total Income in Q3FY26

Veerhealth Care Limited, a company specializing in Ayurvedic medicines and oral care products, has reported a robust 474.18% YoY growth in Profit After Tax (PAT) at INR 0.40 Crore and a 73.13% YoY growth in Total Income at INR 6.96 Crore in Q3FY26. The company is expecting substantial growth in USA export business due to reduced tariffs under the India-EU Trade Deal 2026. Veerhealth Care has received USFDA clearance for Drug (OTC) products, enabling exports to the USA and other international markets. The company is also working towards scaling its manufacturing and export operations for products under the medical device category in the U.S. market. Discussions are ongoing with a major Russian group for oral care exports, and the company has commenced production at a new facility with in-house plastic molding for packaging and backward integration.